HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Siliconchiptechnology-based MMP-7 analysis in urine: an option for preoperative identification of lymph node metastasis in bladder cancer].

AbstractBACKGROUND:
Early detection of metastases in muscle-invasive bladder cancer is crucial. Current imaging techniques provide only limited sensitivity for the detection of low volume metastases. Molecular markers and new rapid analysis techniques are therefore needed to improve metastasis detection sensitivity. High urinary matrix metalloproteinase 7 (MMP 7) levels were previously shown to be correlated with the presence of lymph node metastases. In the present study we applied a new innovative antibody-based electrical biochip technology for the quantitative detection of urinary MMP 7.
MATERIALS AND METHODS:
Preoperative urine samples were acquired from 30 bladder cancer patients (15xN0 and 15xN1-2) who underwent cystectomy because of muscle-invasive bladder cancer. In addition, urine samples of 15 age-matched healthy individuals were also collected. The MMP 7 analyses were performed using electrical biochip technology and a standard ELISA technique in parallel.
RESULTS:
Urinary MMP 7 concentrations measured by biochip technology were significantly higher in patients with metastatic bladder cancer compared to those with organ-confined cancer. The sensitivity for the detection of lymph node metastases was over 70 % using the biochip technology.
CONCLUSIONS:
These results confirm MMP 7 as a promising metastasis marker in bladder cancer. The new electrical biochip technology provides a rapid and reliable quantitative method for measurement of protein markers in urine.
AuthorsT Jäger, S Tschirdewahn, F Vom Dorp, G Piechotta, H Rübben, T Szarvas
JournalDer Urologe. Ausg. A (Urologe A) Vol. 52 Issue 6 Pg. 853-8 (Jun 2013) ISSN: 1433-0563 [Electronic] Germany
Vernacular TitleMMP-7-Bestimmung im Urin basierend auf Siliziumchiptechnologie : Eine Möglichkeit zur präoperativen Identifizierung von Lymphknotenmetastasen beim Harnblasenkarzinom.
PMID23358831 (Publication Type: Controlled Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Biomarkers, Tumor
Topics
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (urine)
  • Biosensing Techniques (instrumentation)
  • Conductometry (instrumentation)
  • Equipment Design
  • Equipment Failure Analysis
  • Female
  • Humans
  • Immunoassay (instrumentation)
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Preoperative Care (statistics & numerical data)
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Urinalysis (instrumentation)
  • Urinary Bladder Neoplasms (blood, diagnosis, secondary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: